Compounds > ici 204,219
Page last updated: 2024-11-05

ici 204,219 and ER-Negative PR-Negative HER2-Negative Breast Cancer

ici 204,219 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suknuntha, K1
Yubolphan, R1
Krueaprasertkul, K1
Srihirun, S1
Sibmooh, N1
Vivithanaporn, P1

Other Studies

1 other study available for ici 204,219 and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells
    Asian Pacific journal of cancer prevention : APJCP, 2018, Mar-27, Volume: 19, Issue:3

    Topics: Acetates; Apoptosis; Cell Cycle; Cell Proliferation; Cyclopropanes; Female; Humans; Indoles; Leukotr

2018